171 related articles for article (PubMed ID: 18763158)
1. Etoposide loaded PLGA and PCL nanoparticles II: biodistribution and pharmacokinetics after radiolabeling with Tc-99m.
Snehalatha M; Venugopal K; Saha RN; Babbar AK; Sharma RK
Drug Deliv; 2008 Jun; 15(5):277-87. PubMed ID: 18763158
[TBL] [Abstract][Full Text] [Related]
2. Novel flavonoid-based biodegradable nanoparticles for effective oral delivery of etoposide by P-glycoprotein modulation: an in vitro, ex vivo and in vivo investigations.
Fatma S; Talegaonkar S; Iqbal Z; Panda AK; Negi LM; Goswami DG; Tariq M
Drug Deliv; 2016; 23(2):500-11. PubMed ID: 24937381
[TBL] [Abstract][Full Text] [Related]
3. Influence of administration route on tumor uptake and biodistribution of etoposide loaded solid lipid nanoparticles in Dalton's lymphoma tumor bearing mice.
Harivardhan Reddy L; Sharma RK; Chuttani K; Mishra AK; Murthy RS
J Control Release; 2005 Jul; 105(3):185-98. PubMed ID: 15921775
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and tissue distribution of liposomal etoposide in rats.
Sistla A; Smith DJ; Kobrinsky NL; Kumar K
Drug Deliv; 2009 Nov; 16(8):423-9. PubMed ID: 19839786
[TBL] [Abstract][Full Text] [Related]
5. Accelerated blood clearance of PEGylated PLGA nanoparticles following repeated injections: effects of polymer dose, PEG coating, and encapsulated anticancer drug.
Saadati R; Dadashzadeh S; Abbasian Z; Soleimanjahi H
Pharm Res; 2013 Apr; 30(4):985-95. PubMed ID: 23184228
[TBL] [Abstract][Full Text] [Related]
6. Etoposide-incorporated tripalmitin nanoparticles with different surface charge: formulation, characterization, radiolabeling, and biodistribution studies.
Reddy LH; Sharma RK; Chuttani K; Mishra AK; Murthy RR
AAPS J; 2004 Oct; 6(3):e23. PubMed ID: 15760108
[TBL] [Abstract][Full Text] [Related]
7. Novel docetaxel chitosan-coated PLGA/PCL nanoparticles with magnified cytotoxicity and bioavailability.
Badran MM; Alomrani AH; Harisa GI; Ashour AE; Kumar A; Yassin AE
Biomed Pharmacother; 2018 Oct; 106():1461-1468. PubMed ID: 30119220
[TBL] [Abstract][Full Text] [Related]
8. Effect of Size on the Biodistribution and Blood Clearance of Etoposide-Loaded PLGA Nanoparticles.
Yadav KS; Chuttani K; Mishra AK; Sawant KK
PDA J Pharm Sci Technol; 2011; 65(2):131-9. PubMed ID: 21502074
[TBL] [Abstract][Full Text] [Related]
9. Freeze-drying of polycaprolactone and poly(D,L-lactic-glycolic) nanoparticles induce minor particle size changes affecting the oral pharmacokinetics of loaded drugs.
Saez A; Guzmán M; Molpeceres J; Aberturas MR
Eur J Pharm Biopharm; 2000 Nov; 50(3):379-87. PubMed ID: 11072195
[TBL] [Abstract][Full Text] [Related]
10. Formulation optimization of etoposide loaded PLGA nanoparticles by double factorial design and their evaluation.
Yadav KS; Sawant KK
Curr Drug Deliv; 2010 Jan; 7(1):51-64. PubMed ID: 20044908
[TBL] [Abstract][Full Text] [Related]
11. Ursolic Acid Loaded PLGA Nanoparticles: in vitro and in vivo Evaluation to Explore Tumor Targeting Ability on B16F10 Melanoma Cell Lines.
Baishya R; Nayak DK; Kumar D; Sinha S; Gupta A; Ganguly S; Debnath MC
Pharm Res; 2016 Nov; 33(11):2691-703. PubMed ID: 27431865
[TBL] [Abstract][Full Text] [Related]
12. Etoposide loaded solid lipid nanoparticles for curtailing B16F10 melanoma colonization in lung.
Athawale RB; Jain DS; Singh KK; Gude RP
Biomed Pharmacother; 2014 Mar; 68(2):231-40. PubMed ID: 24560352
[TBL] [Abstract][Full Text] [Related]
13. Etoposide encapsulation in surface-modified poly(lactide-co-glycolide) nanoparticles strongly enhances glioma antitumor efficiency.
Callewaert M; Dukic S; Van Gulick L; Vittier M; Gafa V; Andry MC; Molinari M; Roullin VG
J Biomed Mater Res A; 2013 May; 101(5):1319-27. PubMed ID: 23065812
[TBL] [Abstract][Full Text] [Related]
14. Development of etoposide-loaded bovine serum albumin nanosuspensions for parenteral delivery.
Wang Z; Li Z; Zhang D; Miao L; Huang G
Drug Deliv; 2015 Jan; 22(1):79-85. PubMed ID: 24401038
[TBL] [Abstract][Full Text] [Related]
15. Modification of PLGA nanoparticles for improved properties as a 99mTc-labeled agent in sentinel lymph node detection.
Subramanian S; Pandey U; Gugulothu D; Patravale V; Samuel G
Cancer Biother Radiopharm; 2013 Oct; 28(8):598-606. PubMed ID: 23705864
[TBL] [Abstract][Full Text] [Related]
16. Chloramphenicol-incorporated poly lactide-co-glycolide (PLGA) nanoparticles: formulation, characterization, technetium-99m labeling and biodistribution studies.
Halder KK; Mandal B; Debnath MC; Bera H; Ghosh LK; Gupta BK
J Drug Target; 2008 May; 16(4):311-20. PubMed ID: 18446610
[TBL] [Abstract][Full Text] [Related]
17. Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile.
Rafiei P; Haddadi A
Int J Nanomedicine; 2017; 12():935-947. PubMed ID: 28184163
[TBL] [Abstract][Full Text] [Related]
18. Sparfloxacin-loaded PLGA nanoparticles for sustained ocular drug delivery.
Gupta H; Aqil M; Khar RK; Ali A; Bhatnagar A; Mittal G
Nanomedicine; 2010 Apr; 6(2):324-33. PubMed ID: 19857606
[TBL] [Abstract][Full Text] [Related]
19. Technetium-99m-labeled poly(DL-lactide-co-glycolide) nanoparticles as an alternative for sentinel lymph node imaging.
Subramanian S; Dandekar P; Jain R; Pandey U; Samuel G; Hassan PA; Patravale V; Venkatesh M
Cancer Biother Radiopharm; 2010 Dec; 25(6):637-44. PubMed ID: 21204757
[TBL] [Abstract][Full Text] [Related]
20. A lyophilized etoposide submicron emulsion with a high drug loading for intravenous injection: preparation, evaluation, and pharmacokinetics in rats.
Chen H; Shi S; Zhao M; Zhang L; He H; Tang X
Drug Dev Ind Pharm; 2010 Dec; 36(12):1444-53. PubMed ID: 21050136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
